An antibiotic that selectively inhibits cellular lipid biosynthesis (IC50 = 0.1 μM) by targeting FabF/B, an enzyme important for the biosynthesis of fatty acids; also inhibits mammalian fatty acid synthase, which reduces liver triglyceride levels and improves insulin sensitivity in a diabetic mouse model.